Prognostic Value of IMP3 Expression in Squamous Cervical Cancer.
Tanja Krešić1,2, Marko Klarić3, Senija Eminović4
1Department of Gynecology and obstretics, University Hospital Mostar.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|October 1, 2024
View abstract on PubMed
Summary
Investigating the protein IMP3 in early-stage cervical cancer revealed no significant link to patient survival. While IMP3 correlates with advanced disease indicators, its utility as a prognostic factor in early stages is limited.
Area of Science:
- Oncology
- Biomarker Research
Background:
- Cervical cancer is a leading cause of cancer death in women globally, particularly in developing nations.
- Tumor biomarkers are crucial for early diagnosis and improved treatment strategies.
- Insulin-like growth factor 2 mRNA-binding protein 3 (IMP3) is linked to tumor invasiveness and aggressive characteristics.
Purpose of the Study:
- To evaluate the prognostic value of IMP3 expression in early-stage squamous cell cervical cancer.
- To determine the association between IMP3 levels and disease-free survival and overall survival.
Main Methods:
- Analysis of IMP3 protein expression in tumor samples from 80 patients with first-stage squamous cell cervical cancer.
- Correlation of IMP3 expression with clinical-pathological indicators and survival outcomes.
Main Results:
- No statistically significant association was found between IMP3 expression and disease-free period or overall survival.
- IMP3 expression showed an association with clinical-pathological indicators of advanced disease.
Conclusions:
- IMP3 protein expression analysis has limited utility as a prognostic factor in patients with early-stage cervical cancer.
- Further research may be needed to clarify the role of IMP3 in different cancer stages or contexts.
